Your browser doesn't support javascript.
loading
Genome-wide case-only analysis of gene-gene interactions with known Parkinson's disease risk variants reveals link between LRRK2 and SYT10.
Aleknonyte-Resch, Milda; Trinh, Joanne; Leonard, Hampton; Delcambre, Sylvie; Leitão, Elsa; Lai, Dongbing; Smajic, Semra; Orr-Urtreger, Avi; Thaler, Avner; Blauwendraat, Cornelis; Sharma, Arunabh; Makarious, Mary B; Kim, Jonggeol Jeff; Lake, Julie; Rahmati, Pegah; Freitag-Wolf, Sandra; Seibler, Philip; Foroud, Tatiana; Singleton, Andrew B; Grünewald, Anne; Kaiser, Frank; Klein, Christine; Krawczak, Michael; Dempfle, Astrid.
Afiliación
  • Aleknonyte-Resch M; Institute of Medical Informatics and Statistics, Kiel University, Kiel, Germany.
  • Trinh J; Department of Computer Science, Kiel University, Kiel, Germany.
  • Leonard H; Institute of Neurogenetics, University of Lübeck, University Medical Center Schleswig-Holstein, Campus Lübeck, Germany.
  • Delcambre S; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Leitão E; Data Tecnica International LLC, Glen Echo, MD, USA.
  • Lai D; Center for Alzheimer's and Related Dementias, National Institute on Aging, Bethesda, MD, USA.
  • Smajic S; Molecular and Functional Neurobiology Group, Luxembourg Centre for Systems Biomedicine, Esch-sur-Alzette, Luxembourg.
  • Orr-Urtreger A; Institute of Human Genetics, University Hospital Essen, Essen, Germany.
  • Thaler A; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Blauwendraat C; Molecular and Functional Neurobiology Group, Luxembourg Centre for Systems Biomedicine, Esch-sur-Alzette, Luxembourg.
  • Sharma A; Neurological Institute, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
  • Makarious MB; Neurological Institute, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
  • Kim JJ; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Lake J; Center for Alzheimer's and Related Dementias, National Institute on Aging, Bethesda, MD, USA.
  • Rahmati P; Institute of Medical Informatics and Statistics, Kiel University, Kiel, Germany.
  • Freitag-Wolf S; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Seibler P; Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology, London, UK.
  • Foroud T; UCL Movement Disorders Centre, University College London, London, UK.
  • Singleton AB; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Grünewald A; Institute of Medical Informatics and Statistics, Kiel University, Kiel, Germany.
  • Kaiser F; Institute of Medical Informatics and Statistics, Kiel University, Kiel, Germany.
  • Klein C; Institute of Neurogenetics, University of Lübeck, University Medical Center Schleswig-Holstein, Campus Lübeck, Germany.
  • Krawczak M; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Dempfle A; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
NPJ Parkinsons Dis ; 9(1): 102, 2023 Jun 29.
Article en En | MEDLINE | ID: mdl-37386035
The effects of one genetic factor upon Parkinson's disease (PD) risk may be modified by other genetic factors. Such gene-gene interaction (G×G) could explain some of the 'missing heritability' of PD and the reduced penetrance of known PD risk variants. Using the largest single nucleotide polymorphism (SNP) genotype data set currently available for PD (18,688 patients), provided by the International Parkinson's Disease Genomics Consortium, we studied G×G with a case-only (CO) design. To this end, we paired each of 90 SNPs previously reported to be associated with PD with one of 7.8 million quality-controlled SNPs from a genome-wide panel. Support of any putative G×G interactions found was sought by the analysis of independent genotype-phenotype and experimental data. A total of 116 significant pairwise SNP genotype associations were identified in PD cases, pointing towards G×G. The most prominent associations involved a region on chromosome 12q containing SNP rs76904798, which is a non-coding variant of the LRRK2 gene. It yielded the lowest interaction p-value overall with SNP rs1007709 in the promoter region of the SYT10 gene (interaction OR = 1.80, 95% CI: 1.65-1.95, p = 2.7 × 10-43). SNPs around SYT10 were also associated with the age-at-onset of PD in an independent cohort of carriers of LRRK2 mutation p.G2019S. Moreover, SYT10 gene expression during neuronal development was found to differ between cells from affected and non-affected p.G2019S carriers. G×G interaction on PD risk, involving the LRRK2 and SYT10 gene regions, is biologically plausible owing to the known link between PD and LRRK2, its involvement in neural plasticity, and the contribution of SYT10 to the exocytosis of secretory vesicles in neurons.

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Parkinsons Dis Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Parkinsons Dis Año: 2023 Tipo del documento: Article País de afiliación: Alemania